Evidence map›Paper›PMID 32419790›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2020

Analysis of the Molecular Mechanism of Acute Coronary Syndrome Based on circRNA-miRNA Network Regulation.

Fei Lin, YaMing Yang, Quan Guo, Mingzhang Xie, Siyu Sun, Xiulong Wang, Dongxu Li, Guhao Zhang, Meng Li, Jie Wang and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Circular RNAs as Novel Biomarkers and Application in Cardiovascular Diseases.Advances in experimental medicine and biology · 2025
    Review
  4. Article
  5. CircRNA-mediated regulation of cardiovascular disease.Frontiers in cardiovascular medicine · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Circular RNAs and Cardiovascular Regeneration.Frontiers in cardiovascular medicine · 2021
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Fei LinThe First Hospital of Xinxiang Medical University, Xinxiang, Henan 453100, China.ORCID https://orcid.org/0000-0003-0130-9985
YaMing YangThe First Hospital of Xinxiang Medical University, Xinxiang, Henan 453100, China.
Quan GuoThe First Hospital of Xinxiang Medical University, Xinxiang, Henan 453100, China.
Mingzhang XieThe First Hospital of Xinxiang Medical University, Xinxiang, Henan 453100, China.
Siyu SunThe First Hospital of Xinxiang Medical University, Xinxiang, Henan 453100, China.
Xiulong WangThe First Hospital of Xinxiang Medical University, Xinxiang, Henan 453100, China.
Dongxu LiThe First Hospital of Xinxiang Medical University, Xinxiang, Henan 453100, China.
Guhao ZhangThe First Hospital of Xinxiang Medical University, Xinxiang, Henan 453100, China.
Meng LiThe First Hospital of Xinxiang Medical University, Xinxiang, Henan 453100, China.
Jie WangGuang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.ORCID https://orcid.org/0000-0001-7870-0646
Guoan ZhaoThe First Hospital of Xinxiang Medical University, Xinxiang, Henan 453100, China.ORCID https://orcid.org/0000-0003-1266-7374
Xinxiang Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith the development of biological technology, biomarkers for the prevention and diagnosis of acute coronary syndrome (ACS) have become increasingly evident. However, the study of novel circular RNAs (circRNAs) in ACS is still in progress. This study aimed to investigate whether the regulation of circRNA-miRNA networks is involved in ACS pathogenesis.

methodsWe used microarray analysis to detect significantly expressed circRNAs and miRNAs in the peripheral blood of patients in the control group (CG) and ACS groups, including an unstable angina pectoris (UAP) group and an acute myocardial infarction (AMI) group. A circRNA-miRNA interaction network analysis was carried out with open-source bioinformatics. The gene ontology (GO), pathway, and disease enrichment analyses for differentially expressed circRNAs were further analysed with hierarchical clustering.

resultsA total of 266 circRNAs (121 upregulated and 145 downregulated,

conclusionCircRNAs are closely related to the pathological process of ACS via a mechanism that may be related to the up- or down-regulation of circRNAs and miRNAs and circRNA-miRNA coexpression. The metabolic pathways, signalling pathways, and diseases affected by these circRNAs can be predicted by enrichment analysis.

Identifiers

PMID32419790
PMCPMC7206869
OpenAlexW3023480015

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.